JP2002508326A5 - - Google Patents

Download PDF

Info

Publication number
JP2002508326A5
JP2002508326A5 JP2000538696A JP2000538696A JP2002508326A5 JP 2002508326 A5 JP2002508326 A5 JP 2002508326A5 JP 2000538696 A JP2000538696 A JP 2000538696A JP 2000538696 A JP2000538696 A JP 2000538696A JP 2002508326 A5 JP2002508326 A5 JP 2002508326A5
Authority
JP
Japan
Prior art keywords
alkyl
aryl
aminocarbonyl
amino
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000538696A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002508326A (ja
Filing date
Publication date
Priority claimed from GBGB9807384.4A external-priority patent/GB9807384D0/en
Priority claimed from GBGB9815803.3A external-priority patent/GB9815803D0/en
Application filed filed Critical
Priority claimed from PCT/US1998/026485 external-priority patent/WO1999030713A1/en
Publication of JP2002508326A publication Critical patent/JP2002508326A/ja
Publication of JP2002508326A5 publication Critical patent/JP2002508326A5/ja
Withdrawn legal-status Critical Current

Links

JP2000538696A 1997-12-17 1998-12-14 インテグリン受容体拮抗薬 Withdrawn JP2002508326A (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US6990997P 1997-12-17 1997-12-17
GBGB9807384.4A GB9807384D0 (en) 1998-04-06 1998-04-06 Vitronectin receptor antagonists
US8325098P 1998-04-27 1998-04-27
US9263098P 1998-07-13 1998-07-13
GB9807384.4 1998-07-21
GB60/083,250 1998-07-21
GBGB9815803.3A GB9815803D0 (en) 1998-07-21 1998-07-21 Vitronectin receptor antagonists
GB60/069,909 1998-07-21
GB60/092,630 1998-07-21
GB9815803.3 1998-07-21
PCT/US1998/026485 WO1999030713A1 (en) 1997-12-17 1998-12-14 Integrin receptor antagonists

Publications (2)

Publication Number Publication Date
JP2002508326A JP2002508326A (ja) 2002-03-19
JP2002508326A5 true JP2002508326A5 (cg-RX-API-DMAC7.html) 2006-02-02

Family

ID=27517454

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000538696A Withdrawn JP2002508326A (ja) 1997-12-17 1998-12-14 インテグリン受容体拮抗薬

Country Status (8)

Country Link
EP (1) EP1044001B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002508326A (cg-RX-API-DMAC7.html)
AT (1) ATE299023T1 (cg-RX-API-DMAC7.html)
AU (1) AU738452B2 (cg-RX-API-DMAC7.html)
CA (1) CA2315232A1 (cg-RX-API-DMAC7.html)
DE (1) DE69830806T2 (cg-RX-API-DMAC7.html)
ES (1) ES2243015T3 (cg-RX-API-DMAC7.html)
WO (1) WO1999030713A1 (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000006169A1 (en) * 1998-07-29 2000-02-10 Merck & Co., Inc. Integrin receptor antagonists
AU748621B2 (en) * 1998-08-13 2002-06-06 Merck & Co., Inc. Integrin receptor antagonists
WO2000047207A1 (en) 1999-02-09 2000-08-17 Bristol-Myers Squibb Company LACTAM INHIBITORS OF FXa AND METHOD
BR0009739A (pt) 1999-04-13 2002-04-09 Basf Ag Composto, medicamento, preparação farmacêutica, e, usos de um elemento estrutural, de um composto e de uma preparação farmacêutica
DE60035779T2 (de) 1999-06-02 2008-04-30 Merck & Co., Inc. Alpha v integrin-rezeptor antagonisten
US6514964B1 (en) 1999-09-27 2003-02-04 Amgen Inc. Fused cycloheptane and fused azacycloheptane compounds and their methods of use
EP1229910A4 (en) 1999-10-04 2003-10-01 Merck & Co Inc integrin
US6849639B2 (en) 1999-12-14 2005-02-01 Amgen Inc. Integrin inhibitors and their methods of use
WO2001053297A1 (en) 2000-01-20 2001-07-26 Merck & Co., Inc. Alpha v integrin receptor antagonists
JP2004511434A (ja) 2000-06-15 2004-04-15 ファルマシア・コーポレーション インテグリン受容体アンタゴニストとしてのヘテロアリールアルカン酸
US6511973B2 (en) 2000-08-02 2003-01-28 Bristol-Myers Squibb Co. Lactam inhibitors of FXa and method
WO2002022615A1 (en) 2000-09-14 2002-03-21 Merck & Co., Inc. Alpha v integrin receptor antagonists
WO2002060438A1 (en) 2001-01-29 2002-08-08 3-Dimensional Pharmaceuticals, Inc. Substituted indoles and their use as integrin antagonists
CN1247258C (zh) 2001-04-24 2006-03-29 默克专利有限公司 使用抗血管生成剂和TNFα的联合疗法
US6872730B2 (en) 2001-04-27 2005-03-29 3-Dimensional Pharmaceuticals, Inc. Substituted benzofurans and benzothiophenes, methods of making and methods of use as integrin antagonists
EP1539739B1 (en) * 2002-08-16 2010-11-24 Janssen Pharmaceutica NV Piperidinyl compounds that selectively bind integrins
BR0316876A (pt) 2002-12-20 2005-10-25 Pharmacia Corp Compostos de tiazol e composição farmacêutica compreendendo o mesmo
UA87854C2 (en) 2004-06-07 2009-08-25 Мерк Энд Ко., Инк. N-(2-benzyl)-2-phenylbutanamides as androgen receptor modulators
KR20080089489A (ko) 2006-01-18 2008-10-06 메르크 파텐트 게엠베하 인테그린 리간드를 사용하는 암치료용 특이적 요법
EA017864B1 (ru) 2007-01-18 2013-03-29 Мерк Патент Гмбх Специфическая терапия и лекарственное средство на основе интегриновых лигандов для лечения рака
AU2010252280A1 (en) 2009-05-25 2012-01-19 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
DK3929196T3 (da) 2013-09-24 2023-09-25 Fujifilm Corp Farmaceutisk sammensætning af en nitrogenholdig forbindelse eller salt deraf, eller metalkompleks deraf
ES2864079T3 (es) 2014-05-30 2021-10-13 Pfizer Derivados de carbonitrilo como moduladores selectivos del receptor de andrógenos
US11046685B2 (en) 2017-02-28 2021-06-29 Morphic Therapeutic, Inc. Inhibitors of (α-v)(β-6) integrin
EP4159727B1 (en) 2017-02-28 2026-04-08 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin
PT3844162T (pt) 2018-08-29 2025-03-28 Morphic Therapeutic Inc Inibidores da integrina alfa v beta6
WO2020047208A1 (en) 2018-08-29 2020-03-05 Morphic Therapeutic, Inc. Inhibitors of (alpha-v)(beta-6) integrin
AU2019327475B2 (en) 2018-08-29 2025-06-05 Morphic Therapeutic, Inc. INHIBITING αV β6 INTEGRIN
DK3873884T3 (da) 2018-10-30 2025-02-17 Gilead Sciences Inc 3-(quinolin-8-yl)-1,4-dihydropyrido[3,4-d]pyrimidin-2,4-dion-derivater som alpha4beta7-integrinhæmmere til behandling af inflammatoriske sygdomme
WO2020092401A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. COMPOUNDS FOR INHIBITION OF ALPHA 4β7 INTEGRIN
ES2987796T3 (es) 2018-10-30 2024-11-18 Gilead Sciences Inc Derivados de N-benzoil-fenilalanina como inhibidores de la integrina alfa4beta7 para el tratamiento de enfermedades inflamatorias
WO2020092394A1 (en) 2018-10-30 2020-05-07 Gilead Sciences, Inc. Imidazopyridine derivatives as alpha4beta7 integrin inhibitors
AU2020329207B2 (en) 2019-08-14 2024-02-29 Gilead Sciences, Inc. Compounds for inhibition of alpha 4 beta 7 integrin
WO2023275715A1 (en) 2021-06-30 2023-01-05 Pfizer Inc. Metabolites of selective androgen receptor modulators

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929618A (en) * 1988-03-25 1990-05-29 Ube Industries, Ltd. Piperdine and piperazine derivatives, and antihistaminic pharmaceutical compositions containing the same

Similar Documents

Publication Publication Date Title
ES2609767T3 (es) Combinaciones de un inhibidor de PI3K y un inhibidor de MEK
RU2483061C2 (ru) Тетрагидропиранохроменовые ингибиторы гамма-секретазы
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
JP2006522813A5 (cg-RX-API-DMAC7.html)
CA2373653C (en) New use of compounds as antibacterial agents
EP3189854B1 (en) Vaccine composition for transdermal or transmucosal administration
JP2003500442A5 (cg-RX-API-DMAC7.html)
JP2018505169A5 (cg-RX-API-DMAC7.html)
KR20220003552A (ko) 레날리도미드 및 다른 면역조정제의 연속적 전달
JP2004517843A5 (cg-RX-API-DMAC7.html)
JP2006508091A5 (cg-RX-API-DMAC7.html)
RU96120189A (ru) Новые фармацевтические препараты и способы их получения
JP2004533428A5 (cg-RX-API-DMAC7.html)
CA2440037A1 (en) Benzimidazole derivatives for modulating the rage receptor
JP2000512993A (ja) H▲上+▼,k▲上+▼−atpアーゼ阻害剤の投与計画
WO2004052847A3 (en) Tricyclic steroid hormone nuclear receptor modulators
EA200000700A3 (ru) НОВЫЕ β- КАРБОЛИНОВЫЕ СОЕДИНЕНИЯ, СПОСОБ ИХ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ИХ
RU99101081A (ru) Режим введения ингибиторов н+, к+-атфазы
JP2002542298A5 (cg-RX-API-DMAC7.html)
EP1125936A3 (en) Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases
CA2415476C (en) Matrix controlled transdermal system for stabile derivatives of ace inhibitors
JPH1036365A5 (cg-RX-API-DMAC7.html)
JP2006509759A (ja) パレコキシブ(parecoxib)、バルデコキシブ(valdecoxib)およびベンゾピラン誘導体のような水溶性の選択的シクロオキシゲナーゼ−2阻害剤の経皮投与
WO2005065664A8 (en) Pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
MXPA05004990A (es) Parche de inhibidor selectivo de ciclooxigenasa-2.